Connection

Helmut Albrecht to Humans

Back to Details
This is a "connection" page, showing publications Helmut Albrecht has written about Humans.
Helmut Albrecht
Connection Strength
0.446
Humans
  1. HIV community viral load trends in South Carolina. Int J STD AIDS. 2017 03; 28(3):265-276.
    View in: PubMed
    Score: 0.021
  2. Sexual Orientation and Risk. Am J Public Health. 2015 Sep; 105(9):e6.
    View in: PubMed
    Score: 0.020
  3. Rural-urban differences in HIV viral loads and progression to AIDS among new HIV cases. South Med J. 2015 Mar; 108(3):180-8.
    View in: PubMed
    Score: 0.019
  4. Clostridium difficile: case report and concise review of fecal microbiota transplantation. J S C Med Assoc. 2013 Jun; 109(2):62-6.
    View in: PubMed
    Score: 0.017
  5. Patient-reported outcomes to assess the efficacy of extended-release guaifenesin for the treatment of acute respiratory tract infection symptoms. Respir Res. 2012 Dec 27; 13:118.
    View in: PubMed
    Score: 0.016
  6. Barriers to care and service needs among chronically homeless persons in a housing first program. Prof Case Manag. 2012 Nov-Dec; 17(6):278-84.
    View in: PubMed
    Score: 0.016
  7. Role of rifampin-based combination therapy for severe community-acquired Legionella pneumophila pneumonia. Ann Pharmacother. 2011 Jul; 45(7-8):967-76.
    View in: PubMed
    Score: 0.015
  8. New HCV treatment paradigms--now also for patients with HIV. J Watch AIDS Clin Care. 2011 May; 23(5):40.
    View in: PubMed
    Score: 0.015
  9. Report from the 17th Conference on Retroviruses and Opportunistic Infections. CCR5 antagonists--out with the old, in with the new? J Watch AIDS Clin Care. 2010 Apr; 22(4):32.
    View in: PubMed
    Score: 0.014
  10. Raltegravir--beauty and the beast. Both the advantages and the limitations of this integrase inhibitor were evident this year. J Watch AIDS Clin Care. 2010 Jan; 22(1):4.
    View in: PubMed
    Score: 0.013
  11. HIV drug pipeline promises more fixed-dose combinations. By 2011, providers and patients may be able to choose between several "one pill, once-daily" options. J Watch AIDS Clin Care. 2010 Jan; 22(1):6.
    View in: PubMed
    Score: 0.013
  12. Report from the 5th IAS Conference on HIV Pathogenesis Treatment and Prevention. ALTAIR--the end of NRTI-only regimes. J Watch AIDS Clin Care. 2009 Oct; 21(10):82.
    View in: PubMed
    Score: 0.013
  13. Report from the 16th Conference on Retroviruses and Opportunistic Infections. SWITCHMRK: an avoidable raltegravir disaster. J Watch AIDS Clin Care. 2009 Apr; 21(4):30-1.
    View in: PubMed
    Score: 0.013
  14. HIV and community-acquired MRSA. J Watch AIDS Clin Care. 2009 Mar; 21(3):21-3.
    View in: PubMed
    Score: 0.013
  15. Report from the 15th Retrovirus Conference. Durability of new agents for treatment-experienced patients. AIDS Clin Care. 2008 Apr; 20(4):30.
    View in: PubMed
    Score: 0.012
  16. Report from the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention. When to start HIV treatment in infants. AIDS Clin Care. 2007 Oct; 19(10):82-3.
    View in: PubMed
    Score: 0.011
  17. A click chemistry amplified nanopore assay for ultrasensitive quantification of HIV-1 p24 antigen in clinical samples. Nat Commun. 2022 Nov 11; 13(1):6852.
    View in: PubMed
    Score: 0.008
  18. Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIV. J Acquir Immune Defic Syndr. 2022 08 01; 90(4):377-381.
    View in: PubMed
    Score: 0.008
  19. Characterization of Altered Gene Expression and Histone Methylation in Peripheral Blood Mononuclear Cells Regulating Inflammation in COVID-19 Patients. J Immunol. 2022 04 15; 208(8):1968-1977.
    View in: PubMed
    Score: 0.008
  20. SARS-CoV-2 Impairs Dendritic Cells and Regulates DC-SIGN Gene Expression in Tissues. Int J Mol Sci. 2021 Aug 26; 22(17).
    View in: PubMed
    Score: 0.007
  21. Multiplex quantitative detection of SARS-CoV-2 specific IgG and IgM antibodies based on DNA-assisted nanopore sensing. Biosens Bioelectron. 2021 Jun 01; 181:113134.
    View in: PubMed
    Score: 0.007
  22. Cholesterol: A new game player accelerating vasculopathy caused by SARS-CoV-2? Am J Physiol Endocrinol Metab. 2020 07 01; 319(1):E197-E202.
    View in: PubMed
    Score: 0.007
  23. Co-formulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial. Lancet HIV. 2019 06; 6(6):e364-e372.
    View in: PubMed
    Score: 0.006
  24. Seasonal variation in antimicrobial resistance rates of community-acquired Escherichia coli bloodstream isolates. Int J Antimicrob Agents. 2019 Jul; 54(1):1-7.
    View in: PubMed
    Score: 0.006
  25. Duration of Antimicrobial Therapy for Enterobacteriaceae Bacteremia: Using Convenient End Points for Convenient Conclusions. Clin Infect Dis. 2018 06 01; 66(12):1978-1979.
    View in: PubMed
    Score: 0.006
  26. Cost-Effectiveness Analysis of Early vs Late Diagnosis of HIV-Infected Patients in South Carolina. South Med J. 2018 06; 111(6):355-358.
    View in: PubMed
    Score: 0.006
  27. Reply to comments: duration of antimicrobial therapy for Gram-negative bacteremia secondary to urinary source of infection. Infection. 2018 04; 46(2):283-284.
    View in: PubMed
    Score: 0.006
  28. Combination therapy vs. monotherapy for Gram-negative bloodstream infection: matching by predicted prognosis. Int J Antimicrob Agents. 2018 Mar; 51(3):488-492.
    View in: PubMed
    Score: 0.006
  29. Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections. Infection. 2017 Oct; 45(5):613-620.
    View in: PubMed
    Score: 0.006
  30. The Continuum of HIV Care in Rural Communities in the United States and Canada: What Is Known and Future Research Directions. J Acquir Immune Defic Syndr. 2017 05 01; 75(1):35-44.
    View in: PubMed
    Score: 0.006
  31. Application of Fluoroquinolone Resistance Score in Management of Complicated Urinary Tract Infections. Antimicrob Agents Chemother. 2017 05; 61(5).
    View in: PubMed
    Score: 0.006
  32. Clinical Risk Score for Prediction of Extended-Spectrum ?-Lactamase-Producing Enterobacteriaceae in Bloodstream Isolates. Infect Control Hosp Epidemiol. 2017 03; 38(3):266-272.
    View in: PubMed
    Score: 0.005
  33. The South Carolina rural-urban HIV continuum of care. AIDS Care. 2017 07; 29(7):817-822.
    View in: PubMed
    Score: 0.005
  34. Non-tuberculous mycobacterial bloodstream infections in patients with indwelling vascular catheters - the role of sickle cell anaemia. Infect Dis (Lond). 2017 May; 49(5):341-346.
    View in: PubMed
    Score: 0.005
  35. Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis. J Antimicrob Chemother. 2017 01; 72(1):299-304.
    View in: PubMed
    Score: 0.005
  36. Differential effect of prior ?-lactams and fluoroquinolones on risk of bloodstream infections secondary to Pseudomonas aeruginosa. Diagn Microbiol Infect Dis. 2017 Jan; 87(1):87-91.
    View in: PubMed
    Score: 0.005
  37. Effectiveness of oral antibiotics for definitive therapy of Gram-negative bloodstream infections. Int J Antimicrob Agents. 2016 Nov; 48(5):498-503.
    View in: PubMed
    Score: 0.005
  38. Association between chronic hemodialysis and bloodstream infections caused by chromosomally mediated AmpC-producing Enterobacteriaceae. Am J Infect Control. 2016 12 01; 44(12):1611-1616.
    View in: PubMed
    Score: 0.005
  39. Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections. Antimicrob Agents Chemother. 2016 Apr; 60(4):2265-72.
    View in: PubMed
    Score: 0.005
  40. The South Carolina HIV Cascade of Care. South Med J. 2015 Nov; 108(11):670-4.
    View in: PubMed
    Score: 0.005
  41. Disparities in viral load and CD4 count trends among HIV-infected adults in South Carolina. AIDS Patient Care STDS. 2015 Jan; 29(1):26-32.
    View in: PubMed
    Score: 0.005
  42. Pseudozyma spp catheter-associated blood stream infection, an emerging pathogen and brief literature review. BMJ Case Rep. 2014 Dec 12; 2014.
    View in: PubMed
    Score: 0.005
  43. Stratification of the impact of inappropriate empirical antimicrobial therapy for Gram-negative bloodstream infections by predicted prognosis. Antimicrob Agents Chemother. 2015 Jan; 59(1):245-50.
    View in: PubMed
    Score: 0.005
  44. Impact of clinical and therapeutic factors on incident cardiovascular and cerebrovascular events in a population-based cohort of HIV-infected and non-HIV-infected adults. Clin Cardiol. 2014 Sep; 37(9):517-22.
    View in: PubMed
    Score: 0.005
  45. Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial. Lancet Infect Dis. 2013 Nov; 13(11):927-35.
    View in: PubMed
    Score: 0.004
  46. Association of clinical and therapeutic factors with incident dyslipidemia in a cohort of human immunodeficiency virus-infected and non-infected adults: 1994-2011. Metab Syndr Relat Disord. 2013 Dec; 11(6):417-26.
    View in: PubMed
    Score: 0.004
  47. Rare case of rilpivirine-induced severe allergic hepatitis. J Antimicrob Chemother. 2013 Feb; 68(2):484-6.
    View in: PubMed
    Score: 0.004
  48. Transmitted antiretroviral drug resistance in individuals with newly diagnosed HIV infection: South Carolina 2005-2009. South Med J. 2011 Feb; 104(2):95-101.
    View in: PubMed
    Score: 0.004
  49. Bryostatin modulates latent HIV-1 infection via PKC and AMPK signaling but inhibits acute infection in a receptor independent manner. PLoS One. 2010 Jun 16; 5(6):e11160.
    View in: PubMed
    Score: 0.003
  50. Missed opportunities for early HIV diagnosis in correctional facilities. AIDS Patient Care STDS. 2009 Dec; 23(12):1025-32.
    View in: PubMed
    Score: 0.003
  51. Serial knife stabbings with HIV exposure--implications for post-exposure prophylaxis. J Infect. 2010 Jan; 60(1):76-8.
    View in: PubMed
    Score: 0.003
  52. Risk-based HIV testing in South Carolina health care settings failed to identify the majority of infected individuals. AIDS Patient Care STDS. 2009 May; 23(5):339-45.
    View in: PubMed
    Score: 0.003
  53. CD127 and CD25 expression defines CD4+ T cell subsets that are differentially depleted during HIV infection. J Immunol. 2008 Apr 15; 180(8):5582-92.
    View in: PubMed
    Score: 0.003
  54. Epidemiological characterization of individuals with newly reported HIV infection: South Carolina, 2004-2005. Am J Public Health. 2009 Apr; 99 Suppl 1:S111-7.
    View in: PubMed
    Score: 0.003
  55. Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals. J Immunol. 2005 Mar 01; 174(5):2900-9.
    View in: PubMed
    Score: 0.002
  56. Imported malaria at an inner-city hospital in the United States. Am J Med Sci. 2005 Jan; 329(1):6-12.
    View in: PubMed
    Score: 0.002
  57. Early correction of cell cycle perturbations predicts the immunological response to therapy in HIV-infected patients. AIDS. 2004 Feb 20; 18(3):393-402.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.